Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies
- Autores
- Murali, Mahadevamurthy; Gowtham, Hittanahallikoppal Gajendramurthy; Shilpa, Natarajamurthy; Krishnappa, Hemanth Kumar Naguvanahalli; Ledesma, Ana Estela; Jain, Anisha S.; Shati, Ali A.; Alfaifi, Mohammad Y.; Elbehairi, Serag Eldin I.; Achar, Raghu Ram; Silina, Ekaterina; Stupin, Victor; Ortega Castro, Joaquín; Frau, Juan; Flores Holguín, Norma; Amruthesh, Kestur Nagaraj; Shivamallu, Chandan; Kollur, Shiva Prasad; Glossman Mitnik, Daniel
- Año de publicación
- 2022
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- The ever-expanding pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has gained attention as COVID-19 and caused an emergency in public health to an unmatched level to date. However, the treatments used are the only options; currently, no effective and licensed medications are available to combat disease transmission, necessitating further research. In the present study, an in silico-based virtual screening of anti-HIV bioactive compounds from medicinal plants was carried out through molecular docking against the main protease (Mpro) (PDB: 6LU7) of SARS-CoV-2, which is a key enzyme responsible for virus replication. A total of 16 anti-HIV compounds were found to have a binding affinity greater than −8.9 kcal/mol out of 150 compounds screened. Pseudohypericin had a high affinity with the energy of −10.2 kcal/mol, demonstrating amino acid residual interactions with LEU141, GLU166, ARG188, and GLN192, followed by Hypericin (−10.1 kcal/mol). Moreover, the ADME (Absorption, Distribution, Metabolism and Excretion) analysis of Pseudohypericin and Hypericin recorded a low bioavailability (BA) score of 0.17 and violated Lipinski’s rule of drug-likeness. The docking and molecular simulations indicated that the quinone compound, Pseudohypericin, could be tested in vitro and in vivo as potent molecules against COVID-19 disease prior to clinical trials.This was also supported by the theoretical and computational studies conducted. The global and local descriptors, which are the underpinnings of Conceptual Density FunctionalTheory (CDFT) have beenpredicted through successful model chemistry, hoping that they could be of help in the comprehension of the chemical reactivity properties of the molecular systems considered in this study.
Fil: Murali, Mahadevamurthy. University Of Mysore; India
Fil: Gowtham, Hittanahallikoppal Gajendramurthy. Nrupathunga University; India
Fil: Shilpa, Natarajamurthy. University Of Mysore; India
Fil: Krishnappa, Hemanth Kumar Naguvanahalli. University Of Mysore; India
Fil: Ledesma, Ana Estela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet Noa Sur. Centro de Investigación en Biofísica Aplicada y Alimentos. - Universidad Nacional de Santiago del Estero. Centro de Investigación en Biofísica Aplicada y Alimentos; Argentina
Fil: Jain, Anisha S.. University Of Mysore; India
Fil: Shati, Ali A.. King Khalid University; Arabia Saudita
Fil: Alfaifi, Mohammad Y.. Vacsera Holding Company; Egipto
Fil: Elbehairi, Serag Eldin I.. Jss Academy Of Higher Education And Research; India
Fil: Achar, Raghu Ram. Pirogov Russian National Research Medical University; Rusia
Fil: Silina, Ekaterina. Universitat de Les Illesbalears; España
Fil: Stupin, Victor. Centro de Investigaciónen Materiales Avanzados; México
Fil: Ortega Castro, Joaquín. Jss Academy Of Higher Education And Research; India
Fil: Frau, Juan. Universitat de Les Illesbalears; España
Fil: Flores Holguín, Norma. Centro de Investigaciónen Materiales Avanzados; México
Fil: Amruthesh, Kestur Nagaraj. University Of Mysore; India
Fil: Shivamallu, Chandan. Jss Academy Of Higher Education And Research; India
Fil: Kollur, Shiva Prasad. University Of Mysore; India
Fil: Glossman Mitnik, Daniel. Centro de Investigaciónen Materiales Avanzados; México - Materia
-
ANTI-HIV
BIOACTIVE COMPOUNDS
CONCEPTUAL DFT
MAIN PROTEASE
SARS-COV-2
COVID-19 - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
.jpg)
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/214358
Ver los metadatos del registro completo
| id |
CONICETDig_894b59cd41907f572a3b93b0312f5dc8 |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/214358 |
| network_acronym_str |
CONICETDig |
| repository_id_str |
3498 |
| network_name_str |
CONICET Digital (CONICET) |
| spelling |
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT StudiesMurali, MahadevamurthyGowtham, Hittanahallikoppal GajendramurthyShilpa, NatarajamurthyKrishnappa, Hemanth Kumar NaguvanahalliLedesma, Ana EstelaJain, Anisha S.Shati, Ali A.Alfaifi, Mohammad Y.Elbehairi, Serag Eldin I.Achar, Raghu RamSilina, EkaterinaStupin, VictorOrtega Castro, JoaquínFrau, JuanFlores Holguín, NormaAmruthesh, Kestur NagarajShivamallu, ChandanKollur, Shiva PrasadGlossman Mitnik, DanielANTI-HIVBIOACTIVE COMPOUNDSCONCEPTUAL DFTMAIN PROTEASESARS-COV-2COVID-19https://purl.org/becyt/ford/1.4https://purl.org/becyt/ford/1The ever-expanding pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has gained attention as COVID-19 and caused an emergency in public health to an unmatched level to date. However, the treatments used are the only options; currently, no effective and licensed medications are available to combat disease transmission, necessitating further research. In the present study, an in silico-based virtual screening of anti-HIV bioactive compounds from medicinal plants was carried out through molecular docking against the main protease (Mpro) (PDB: 6LU7) of SARS-CoV-2, which is a key enzyme responsible for virus replication. A total of 16 anti-HIV compounds were found to have a binding affinity greater than −8.9 kcal/mol out of 150 compounds screened. Pseudohypericin had a high affinity with the energy of −10.2 kcal/mol, demonstrating amino acid residual interactions with LEU141, GLU166, ARG188, and GLN192, followed by Hypericin (−10.1 kcal/mol). Moreover, the ADME (Absorption, Distribution, Metabolism and Excretion) analysis of Pseudohypericin and Hypericin recorded a low bioavailability (BA) score of 0.17 and violated Lipinski’s rule of drug-likeness. The docking and molecular simulations indicated that the quinone compound, Pseudohypericin, could be tested in vitro and in vivo as potent molecules against COVID-19 disease prior to clinical trials.This was also supported by the theoretical and computational studies conducted. The global and local descriptors, which are the underpinnings of Conceptual Density FunctionalTheory (CDFT) have beenpredicted through successful model chemistry, hoping that they could be of help in the comprehension of the chemical reactivity properties of the molecular systems considered in this study.Fil: Murali, Mahadevamurthy. University Of Mysore; IndiaFil: Gowtham, Hittanahallikoppal Gajendramurthy. Nrupathunga University; IndiaFil: Shilpa, Natarajamurthy. University Of Mysore; IndiaFil: Krishnappa, Hemanth Kumar Naguvanahalli. University Of Mysore; IndiaFil: Ledesma, Ana Estela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet Noa Sur. Centro de Investigación en Biofísica Aplicada y Alimentos. - Universidad Nacional de Santiago del Estero. Centro de Investigación en Biofísica Aplicada y Alimentos; ArgentinaFil: Jain, Anisha S.. University Of Mysore; IndiaFil: Shati, Ali A.. King Khalid University; Arabia SauditaFil: Alfaifi, Mohammad Y.. Vacsera Holding Company; EgiptoFil: Elbehairi, Serag Eldin I.. Jss Academy Of Higher Education And Research; IndiaFil: Achar, Raghu Ram. Pirogov Russian National Research Medical University; RusiaFil: Silina, Ekaterina. Universitat de Les Illesbalears; EspañaFil: Stupin, Victor. Centro de Investigaciónen Materiales Avanzados; MéxicoFil: Ortega Castro, Joaquín. Jss Academy Of Higher Education And Research; IndiaFil: Frau, Juan. Universitat de Les Illesbalears; EspañaFil: Flores Holguín, Norma. Centro de Investigaciónen Materiales Avanzados; MéxicoFil: Amruthesh, Kestur Nagaraj. University Of Mysore; IndiaFil: Shivamallu, Chandan. Jss Academy Of Higher Education And Research; IndiaFil: Kollur, Shiva Prasad. University Of Mysore; IndiaFil: Glossman Mitnik, Daniel. Centro de Investigaciónen Materiales Avanzados; MéxicoMolecular Diversity Preservation International2022-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/214358Murali, Mahadevamurthy; Gowtham, Hittanahallikoppal Gajendramurthy; Shilpa, Natarajamurthy; Krishnappa, Hemanth Kumar Naguvanahalli; Ledesma, Ana Estela; et al.; Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies; Molecular Diversity Preservation International; Molecules; 27; 23; 11-2022; 1-161420-3049CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/1420-3049/27/23/8288info:eu-repo/semantics/altIdentifier/doi/10.3390/molecules27238288info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2026-08-25T14:34:37Zoai:ri.conicet.gov.ar:11336/214358instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982026-08-25 14:34:37.842CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| dc.title.none.fl_str_mv |
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies |
| title |
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies |
| spellingShingle |
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies Murali, Mahadevamurthy ANTI-HIV BIOACTIVE COMPOUNDS CONCEPTUAL DFT MAIN PROTEASE SARS-COV-2 COVID-19 |
| title_short |
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies |
| title_full |
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies |
| title_fullStr |
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies |
| title_full_unstemmed |
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies |
| title_sort |
Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies |
| dc.creator.none.fl_str_mv |
Murali, Mahadevamurthy Gowtham, Hittanahallikoppal Gajendramurthy Shilpa, Natarajamurthy Krishnappa, Hemanth Kumar Naguvanahalli Ledesma, Ana Estela Jain, Anisha S. Shati, Ali A. Alfaifi, Mohammad Y. Elbehairi, Serag Eldin I. Achar, Raghu Ram Silina, Ekaterina Stupin, Victor Ortega Castro, Joaquín Frau, Juan Flores Holguín, Norma Amruthesh, Kestur Nagaraj Shivamallu, Chandan Kollur, Shiva Prasad Glossman Mitnik, Daniel |
| author |
Murali, Mahadevamurthy |
| author_facet |
Murali, Mahadevamurthy Gowtham, Hittanahallikoppal Gajendramurthy Shilpa, Natarajamurthy Krishnappa, Hemanth Kumar Naguvanahalli Ledesma, Ana Estela Jain, Anisha S. Shati, Ali A. Alfaifi, Mohammad Y. Elbehairi, Serag Eldin I. Achar, Raghu Ram Silina, Ekaterina Stupin, Victor Ortega Castro, Joaquín Frau, Juan Flores Holguín, Norma Amruthesh, Kestur Nagaraj Shivamallu, Chandan Kollur, Shiva Prasad Glossman Mitnik, Daniel |
| author_role |
author |
| author2 |
Gowtham, Hittanahallikoppal Gajendramurthy Shilpa, Natarajamurthy Krishnappa, Hemanth Kumar Naguvanahalli Ledesma, Ana Estela Jain, Anisha S. Shati, Ali A. Alfaifi, Mohammad Y. Elbehairi, Serag Eldin I. Achar, Raghu Ram Silina, Ekaterina Stupin, Victor Ortega Castro, Joaquín Frau, Juan Flores Holguín, Norma Amruthesh, Kestur Nagaraj Shivamallu, Chandan Kollur, Shiva Prasad Glossman Mitnik, Daniel |
| author2_role |
author author author author author author author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
ANTI-HIV BIOACTIVE COMPOUNDS CONCEPTUAL DFT MAIN PROTEASE SARS-COV-2 COVID-19 |
| topic |
ANTI-HIV BIOACTIVE COMPOUNDS CONCEPTUAL DFT MAIN PROTEASE SARS-COV-2 COVID-19 |
| purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.4 https://purl.org/becyt/ford/1 |
| dc.description.none.fl_txt_mv |
The ever-expanding pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has gained attention as COVID-19 and caused an emergency in public health to an unmatched level to date. However, the treatments used are the only options; currently, no effective and licensed medications are available to combat disease transmission, necessitating further research. In the present study, an in silico-based virtual screening of anti-HIV bioactive compounds from medicinal plants was carried out through molecular docking against the main protease (Mpro) (PDB: 6LU7) of SARS-CoV-2, which is a key enzyme responsible for virus replication. A total of 16 anti-HIV compounds were found to have a binding affinity greater than −8.9 kcal/mol out of 150 compounds screened. Pseudohypericin had a high affinity with the energy of −10.2 kcal/mol, demonstrating amino acid residual interactions with LEU141, GLU166, ARG188, and GLN192, followed by Hypericin (−10.1 kcal/mol). Moreover, the ADME (Absorption, Distribution, Metabolism and Excretion) analysis of Pseudohypericin and Hypericin recorded a low bioavailability (BA) score of 0.17 and violated Lipinski’s rule of drug-likeness. The docking and molecular simulations indicated that the quinone compound, Pseudohypericin, could be tested in vitro and in vivo as potent molecules against COVID-19 disease prior to clinical trials.This was also supported by the theoretical and computational studies conducted. The global and local descriptors, which are the underpinnings of Conceptual Density FunctionalTheory (CDFT) have beenpredicted through successful model chemistry, hoping that they could be of help in the comprehension of the chemical reactivity properties of the molecular systems considered in this study. Fil: Murali, Mahadevamurthy. University Of Mysore; India Fil: Gowtham, Hittanahallikoppal Gajendramurthy. Nrupathunga University; India Fil: Shilpa, Natarajamurthy. University Of Mysore; India Fil: Krishnappa, Hemanth Kumar Naguvanahalli. University Of Mysore; India Fil: Ledesma, Ana Estela. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet Noa Sur. Centro de Investigación en Biofísica Aplicada y Alimentos. - Universidad Nacional de Santiago del Estero. Centro de Investigación en Biofísica Aplicada y Alimentos; Argentina Fil: Jain, Anisha S.. University Of Mysore; India Fil: Shati, Ali A.. King Khalid University; Arabia Saudita Fil: Alfaifi, Mohammad Y.. Vacsera Holding Company; Egipto Fil: Elbehairi, Serag Eldin I.. Jss Academy Of Higher Education And Research; India Fil: Achar, Raghu Ram. Pirogov Russian National Research Medical University; Rusia Fil: Silina, Ekaterina. Universitat de Les Illesbalears; España Fil: Stupin, Victor. Centro de Investigaciónen Materiales Avanzados; México Fil: Ortega Castro, Joaquín. Jss Academy Of Higher Education And Research; India Fil: Frau, Juan. Universitat de Les Illesbalears; España Fil: Flores Holguín, Norma. Centro de Investigaciónen Materiales Avanzados; México Fil: Amruthesh, Kestur Nagaraj. University Of Mysore; India Fil: Shivamallu, Chandan. Jss Academy Of Higher Education And Research; India Fil: Kollur, Shiva Prasad. University Of Mysore; India Fil: Glossman Mitnik, Daniel. Centro de Investigaciónen Materiales Avanzados; México |
| description |
The ever-expanding pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has gained attention as COVID-19 and caused an emergency in public health to an unmatched level to date. However, the treatments used are the only options; currently, no effective and licensed medications are available to combat disease transmission, necessitating further research. In the present study, an in silico-based virtual screening of anti-HIV bioactive compounds from medicinal plants was carried out through molecular docking against the main protease (Mpro) (PDB: 6LU7) of SARS-CoV-2, which is a key enzyme responsible for virus replication. A total of 16 anti-HIV compounds were found to have a binding affinity greater than −8.9 kcal/mol out of 150 compounds screened. Pseudohypericin had a high affinity with the energy of −10.2 kcal/mol, demonstrating amino acid residual interactions with LEU141, GLU166, ARG188, and GLN192, followed by Hypericin (−10.1 kcal/mol). Moreover, the ADME (Absorption, Distribution, Metabolism and Excretion) analysis of Pseudohypericin and Hypericin recorded a low bioavailability (BA) score of 0.17 and violated Lipinski’s rule of drug-likeness. The docking and molecular simulations indicated that the quinone compound, Pseudohypericin, could be tested in vitro and in vivo as potent molecules against COVID-19 disease prior to clinical trials.This was also supported by the theoretical and computational studies conducted. The global and local descriptors, which are the underpinnings of Conceptual Density FunctionalTheory (CDFT) have beenpredicted through successful model chemistry, hoping that they could be of help in the comprehension of the chemical reactivity properties of the molecular systems considered in this study. |
| publishDate |
2022 |
| dc.date.none.fl_str_mv |
2022-11 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/214358 Murali, Mahadevamurthy; Gowtham, Hittanahallikoppal Gajendramurthy; Shilpa, Natarajamurthy; Krishnappa, Hemanth Kumar Naguvanahalli; Ledesma, Ana Estela; et al.; Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies; Molecular Diversity Preservation International; Molecules; 27; 23; 11-2022; 1-16 1420-3049 CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/214358 |
| identifier_str_mv |
Murali, Mahadevamurthy; Gowtham, Hittanahallikoppal Gajendramurthy; Shilpa, Natarajamurthy; Krishnappa, Hemanth Kumar Naguvanahalli; Ledesma, Ana Estela; et al.; Exploration of Anti-HIV Phytocompounds against SARS-CoV-2 Main Protease: Structure-Based Screening, Molecular Simulation, ADME Analysis and Conceptual DFT Studies; Molecular Diversity Preservation International; Molecules; 27; 23; 11-2022; 1-16 1420-3049 CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/1420-3049/27/23/8288 info:eu-repo/semantics/altIdentifier/doi/10.3390/molecules27238288 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Molecular Diversity Preservation International |
| publisher.none.fl_str_mv |
Molecular Diversity Preservation International |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1874774218197958656 |
| score |
13.364332 |